Contingencies and commitments - Collaborations and License Agreements (Details) - USD ($) |
1 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 16, 2016 |
Feb. 29, 2016 |
Nov. 30, 2015 |
Dec. 31, 2012 |
Dec. 31, 2016 |
Sep. 26, 2016 |
|
| ThermoFisher Scientific | ||||||
| Collaboration and License Agreement | ||||||
| Supply contract agreement period (in years) | 5 years | |||||
| Clinical trials commitment | MD Anderson Strategic Alliance | Minimum | ||||||
| Collaboration and License Agreement | ||||||
| Further potential milestone payments | $ 19,644,000 | |||||
| Collaborative arrangement | Universal Cells, Inc. | ||||||
| Collaboration and License Agreement | ||||||
| Upfront license and startup fees | $ 2,500,000 | |||||
| Milestone payments | $ 3,000,000 | |||||
| Further potential milestone payments | $ 44,000,000 | |||||
| Collaborative arrangement | Life Technologies Corp | ||||||
| Collaboration and License Agreement | ||||||
| Upfront license fees | $ 1,000,000 | |||||
| Minimum annual royalties as a percentage of prior year running royalties (as a percent) | 50.00% | |||||
| X | ||||||||||
- Definition Represents the amount of payments that the entity is required to make under the license agreement, upon achievement of certain development and product milestones. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of milestone payments made by the entity under the license agreement. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of upfront and start-up fees paid. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of upfront license fees paid. No definition available.
|
| X | ||||||||||
- Definition The amount to be paid as minimum annual royalties after the approval of licensed product as a percentage of prior year running royalties. No definition available.
|
| X | ||||||||||
- Definition Agreement period of supply contract. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|